BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses. Gastroenterology. 2019;157:647-659.e4. [PMID: 31014995 DOI: 10.1053/j.gastro.2019.04.016] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 34.3] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Liu R. Long non-coding RNA H19 in the liver-gut axis: A diagnostic marker and therapeutic target for liver diseases. Experimental and Molecular Pathology 2020;115:104472. [DOI: 10.1016/j.yexmp.2020.104472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Wang L, Cao ZM, Zhang LL, Dai XC, Liu ZJ, Zeng YX, Li XY, Wu QJ, Lv WL. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Front Immunol 2022;13:833424. [PMID: 35222423 DOI: 10.3389/fimmu.2022.833424] [Reference Citation Analysis]
3 Pagnini C, Picchianti-Diamanti A, Bruzzese V, Lorenzetti R, Luchetti MM, Martin LSM, Pica R, Scolieri P, Scribano ML, Zampaletta C, Chimenti MS, Lagana B. Vitamin D Signaling in Gastro-Rheumatology: From Immuno-Modulation to Potential Clinical Applications. Int J Mol Sci 2021;22:2456. [PMID: 33671090 DOI: 10.3390/ijms22052456] [Reference Citation Analysis]
4 Myint A, Sauk JS, Limketkai BN. The role of vitamin D in inflammatory bowel disease: a guide for clinical practice. Expert Rev Gastroenterol Hepatol 2020;14:539-52. [PMID: 32543306 DOI: 10.1080/17474124.2020.1775580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Carreras-Torres R, Ibáñez-Sanz G, Obón-Santacana M, Duell EJ, Moreno V. Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study. Sci Rep 2020;10:19273. [PMID: 33159156 DOI: 10.1038/s41598-020-76361-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kitani T, Maddipatla SC, Madupuri R, Greco C, Hartmann J, Baraniuk JN, Vasudevan S. In Search of Newer Targets for Inflammatory Bowel Disease: A Systems and a Network Medicine Approach. Network and Systems Medicine 2021;4:74-87. [DOI: 10.1089/nsm.2020.0012] [Reference Citation Analysis]
7 Agrawal M, Allin KH, Petralia F, Colombel JF, Jess T. Multiomics to elucidate inflammatory bowel disease risk factors and pathways. Nat Rev Gastroenterol Hepatol 2022;19:399-409. [PMID: 35301463 DOI: 10.1038/s41575-022-00593-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Peppas S, Pansieri C, Piovani D, Danese S, Peyrin-Biroulet L, Tsantes AG, Brunetta E, Tsantes AE, Bonovas S. The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases. J Clin Med 2021;10:377. [PMID: 33498197 DOI: 10.3390/jcm10030377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Bonovas S, Pansieri C, Piovani D, Macaluso FS, Orlando A, Festa S, Papi C, Pugliese D, Armuzzi A. Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology. Dig Liver Dis 2022:S1590-8658(22)00134-7. [PMID: 35183439 DOI: 10.1016/j.dld.2022.01.123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Agrawal M, Sabino J, Frias-Gomes C, Hillenbrand CM, Soudant C, Axelrad JE, Shah SC, Ribeiro-Mourão F, Lambin T, Peter I, Colombel JF, Narula N, Torres J. Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses. EClinicalMedicine 2021;36:100884. [PMID: 34308303 DOI: 10.1016/j.eclinm.2021.100884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ban Q, Liu M, Ding N, Chen Y, Lin Q, Zha J, He W. Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions. Front Nutr 2022;9:794169. [DOI: 10.3389/fnut.2022.794169] [Reference Citation Analysis]
12 Cainzos-Achirica M, Glassner K, Zawahir HS, Dey AK, Agrawal T, Quigley EMM, Abraham BP, Acquah I, Yahya T, Mehta NN, Nasir K. Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol 2020;76:2895-905. [PMID: 33303079 DOI: 10.1016/j.jacc.2020.10.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Teich N, Mohl W, Primas C, Novacek G, Gauss A, Walldorf J, Felten G, Atreya R, Kruis W, Bettenworth D, Roznowski AB, Langhorst J, Schmidt K, Bruns T, Stallmach A; German IBD Study Group. Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn's disease: results from a large case-control study. Scand J Gastroenterol 2020;55:1028-34. [PMID: 32730708 DOI: 10.1080/00365521.2020.1797869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Stallmach A, Reuken PA, Grunert P, Teich N. [Inflammatory bowel disease during the COVID-19 pandemic: manifestations and management]. Z Gastroenterol 2022. [PMID: 35148564 DOI: 10.1055/a-1744-6697] [Reference Citation Analysis]
15 Wehkamp J, Stange EF. An Update Review on the Paneth Cell as Key to Ileal Crohn's Disease. Front Immunol 2020;11:646. [PMID: 32351509 DOI: 10.3389/fimmu.2020.00646] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
16 Bangarusamy DK, Lakshmanan AP, Al-Zaidan S, Alabduljabbar S, Terranegra A. Nutri-epigenetics: the effect of maternal diet and early nutrition on the pathogenesis of autoimmune diseases. Minerva Pediatr (Torino) 2021;73:98-110. [PMID: 33880901 DOI: 10.23736/S2724-5276.20.06166-6] [Reference Citation Analysis]
17 Zaidi D, Wine E. Building Fences: How A20 Protects the Intestinal Mucosa in Inflammatory Bowel Diseases. Dig Dis Sci 2020;65:1288-90. [PMID: 31768881 DOI: 10.1007/s10620-019-05964-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Battistini C, Ballan R, Herkenhoff ME, Saad SMI, Sun J. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci 2020;22:E362. [PMID: 33396382 DOI: 10.3390/ijms22010362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
19 Agrawal M, Corn G, Shrestha S, Nielsen NM, Frisch M, Colombel JF, Jess T. Inflammatory bowel diseases among first-generation and second-generation immigrants in Denmark: a population-based cohort study. Gut 2021;70:1037-43. [PMID: 32895335 DOI: 10.1136/gutjnl-2020-321798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Rubbino F, Greco L, di Cristofaro A, Gaiani F, Vetrano S, Laghi L, Bonovas S, Piovani D. Journey through Crohn's Disease Complication: From Fistula Formation to Future Therapies. J Clin Med 2021;10:5548. [PMID: 34884247 DOI: 10.3390/jcm10235548] [Reference Citation Analysis]
21 Ménard A, Smet A. Review: Other Helicobacter species. Helicobacter 2019;24 Suppl 1:e12645. [PMID: 31486233 DOI: 10.1111/hel.12645] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
22 Rychter AM, Ratajczak AE, Szymczak-Tomczak A, Michalak M, Eder P, Dobrowolska A, Krela-Kaźmierczak I. Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease. Nutrients 2021;13:1863. [PMID: 34070791 DOI: 10.3390/nu13061863] [Reference Citation Analysis]
23 Guo N, Zhu Y, Tian D, Zhao Y, Zhang C, Mu C, Han C, Zhu R, Liu X. Role of diet in stroke incidence: an umbrella review of meta-analyses of prospective observational studies. BMC Med 2022;20:194. [PMID: 35606791 DOI: 10.1186/s12916-022-02381-6] [Reference Citation Analysis]
24 Gimier E, Chervy M, Agus A, Sivignon A, Billard E, Privat M, Viala S, Minet-Quinard R, Buisson A, Vazeille E, Barnich N, Denizot J. Methyl-donor supplementation prevents intestinal colonization by Adherent-Invasive E. coli in a mouse model of Crohn's disease. Sci Rep 2020;10:12922. [PMID: 32737335 DOI: 10.1038/s41598-020-69472-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn's disease.Nat Rev Dis Primers. 2020;6:22. [PMID: 32242028 DOI: 10.1038/s41572-020-0156-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 23.5] [Reference Citation Analysis]
26 Vennou KE, Piovani D, Kontou PI, Bonovas S, Bagos PG. Multiple outcome meta-analysis of gene-expression data in inflammatory bowel disease. Genomics 2020;112:1761-7. [DOI: 10.1016/j.ygeno.2019.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
27 Khademi Z, Milajerdi A, Larijani B, Esmaillzadeh A. Dietary Intake of Total Carbohydrates, Sugar and Sugar-Sweetened Beverages, and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Front Nutr 2021;8:707795. [PMID: 34660658 DOI: 10.3389/fnut.2021.707795] [Reference Citation Analysis]
28 Burkhardt W, Rausch T, Klopfleisch R, Blaut M, Braune A. Impact of dietary sulfolipid-derived sulfoquinovose on gut microbiota composition and inflammatory status of colitis-prone interleukin-10-deficient mice. Int J Med Microbiol 2021;311:151494. [PMID: 33711649 DOI: 10.1016/j.ijmm.2021.151494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Dvornikova KA, Bystrova EY, Churilov LP, Lerner A. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection. Mol Biol Rep 2021;48:5745-58. [PMID: 34296352 DOI: 10.1007/s11033-021-06565-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Katsidzira L, Mudombi WF, Makunike-Mutasa R, Yilmaz B, Blank A, Rogler G, Macpherson A, Vavricka S, Gangaidzo I, Misselwitz B. Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case-control study. BMJ Open 2020;10:e039456. [PMID: 33371021 DOI: 10.1136/bmjopen-2020-039456] [Reference Citation Analysis]
31 Vasseur P, Dugelay E, Benamouzig R, Savoye G, Lan A, Srour B, Hercberg S, Touvier M, Hugot JP, Julia C, Buscail C. Dietary Patterns, Ultra-processed Food, and the Risk of Inflammatory Bowel Diseases in the NutriNet-Santé Cohort. Inflamm Bowel Dis 2021;27:65-73. [PMID: 32055825 DOI: 10.1093/ibd/izaa018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
32 Granström AL, Ludvigsson JF, Wester T. Clinical characteristics and validation of diagnosis in individuals with Hirschsprung disease and inflammatory bowel disease. J Pediatr Surg 2020:S0022-3468(20)30845-9. [PMID: 33276971 DOI: 10.1016/j.jpedsurg.2020.11.015] [Reference Citation Analysis]
33 Zielińska M, Szymaszkiewicz A, Jacenik D, Schodel L, Sałaga M, Zatorski H, Kordek R, Becker C, Krajewska WM, Fichna J. Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice. Eur J Pharmacol 2020;885:173463. [PMID: 32835668 DOI: 10.1016/j.ejphar.2020.173463] [Reference Citation Analysis]
34 Li D, Gao C, Zhang F, Yang R, Lan C, Ma Y, Wang J. Seven facts and five initiatives for gut microbiome research. Protein Cell. 2020;11:391-400. [PMID: 32172500 DOI: 10.1007/s13238-020-00697-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Xu M, Shen Y, Cen M, Zhu Y, Cheng F, Tang L, Zheng X, Kim JJ, Dai N, Hu W. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice. J Crohns Colitis 2021;15:1197-210. [PMID: 33417675 DOI: 10.1093/ecco-jcc/jjab003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Tsou AM, Olesen SW, Alm EJ, Snapper SB. 16S rRNA sequencing analysis: the devil is in the details. Gut Microbes 2020;11:1139-42. [PMID: 32329652 DOI: 10.1080/19490976.2020.1747336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Zhong L, Chen W, Wang T, Zeng Q, Lai L, Lai J, Lin J, Tang S. Alcohol and Health Outcomes: An Umbrella Review of Meta-Analyses Base on Prospective Cohort Studies. Front Public Health 2022;10:859947. [DOI: 10.3389/fpubh.2022.859947] [Reference Citation Analysis]
38 Vaccaro JA, Naser SA. The Role of Methyl Donors of the Methionine Cycle in Gastrointestinal Infection and Inflammation. Healthcare 2022;10:61. [DOI: 10.3390/healthcare10010061] [Reference Citation Analysis]
39 Coates MD, Ba DM, Liu G, Dalessio S, Leslie DL, Huang X. Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease. Inflamm Bowel Dis 2021:izab175. [PMID: 34259840 DOI: 10.1093/ibd/izab175] [Reference Citation Analysis]
40 Zhao M, Feng R, Ben-Horin S, Zhuang X, Tian Z, Li X, Ma R, Mao R, Qiu Y, Chen M. Systematic review with meta-analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations. Aliment Pharmacol Ther 2021. [PMID: 34820868 DOI: 10.1111/apt.16703] [Reference Citation Analysis]
41 Furuya Y, Fukai K, Nakazawa S, Kojimahara N, Hoshi K, Toyota A, Tatemichi M. Occupational physical activity differentially affects the risk for developing later-onset Crohn's disease and ulcerative colitis among middle-aged and older populations. Scand J Gastroenterol 2021;:1-8. [PMID: 34762552 DOI: 10.1080/00365521.2021.1999495] [Reference Citation Analysis]
42 Villanacci V, Reggiani-Bonetti L, Salviato T, Leoncini G, Cadei M, Albarello L, Caputo A, Aquilano MC, Battista S, Parente P. Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD). Pathologica 2021;113:39-53. [PMID: 33686309 DOI: 10.32074/1591-951X-235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Bonovas S. Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020;51:820-830. [PMID: 32170782 DOI: 10.1111/apt.15692] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
44 Elkharsawi A, Arnim UV, Schmelz R, Sander C, Stallmach A, Teich N, Walldorf J, Reuken PA. SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease. Z Gastroenterol 2022;60:77-80. [PMID: 35042256 DOI: 10.1055/a-1710-3861] [Reference Citation Analysis]
45 Wang HQ, Zhang WH, Wang YQ, Geng XP, Wang MW, Fan YY, Guan J, Shen JL, Chen X. Colonic vitamin D receptor expression is inversely associated with disease activity and jumonji domain-containing 3 in active ulcerative colitis. World J Gastroenterol 2020; 26(46): 7352-7366 [PMID: 33362389 DOI: 10.3748/wjg.v26.i46.7352] [Reference Citation Analysis]
46 Zhang C, Li J, Xiao M, Wang D, Qu Y, Zou L, Zheng C, Zhang J. Oral colon-targeted mucoadhesive micelles with enzyme-responsive controlled release of curcumin for ulcerative colitis therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.03.110] [Reference Citation Analysis]
47 Mak JWY, Yang S, Stanley A, Lin X, Morrison M, Ching JYL, Niu J, Wilson‐o'brien AL, Feng R, Tang W, Hamilton AL, Or L, Trakman GL, Lin WYY, Sung JJY, Chen MH, Mao Y, Kamm MA, Ng SC. Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study. JGH Open. [DOI: 10.1002/jgh3.12755] [Reference Citation Analysis]
48 Chen W, Li Y, Guo L, Zhang C, Tang S. An umbrella review of systematic reviews and meta-analyses of observational investigations of obstructive sleep apnea and health outcomes. Sleep Breath 2021. [PMID: 33893906 DOI: 10.1007/s11325-021-02384-2] [Reference Citation Analysis]
49 Duus KS, Moos C, Frederiksen P, Andersen V, Heitmann BL. Prenatal and Early Life Exposure to the Danish Mandatory Vitamin D Fortification Policy Might Prevent Inflammatory Bowel Disease Later in Life: A Societal Experiment. Nutrients 2021;13:1367. [PMID: 33921832 DOI: 10.3390/nu13041367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Wibowo S, Subandiyah K, Handono K, Poeranto S. Role of vitamin D in Wnt pathway activation for colonic epithelial cell differentiation. J Taibah Univ Med Sci 2021;16:575-81. [PMID: 34408615 DOI: 10.1016/j.jtumed.2021.01.012] [Reference Citation Analysis]
51 Domislović V, Vranešić Bender D, Barišić A, Brinar M, Ljubas Kelečić D, Rotim C, Novosel M, Matašin M, Krznarić Ž. HIGH PREVALENCE OF UNTREATED AND UNDERTREATED VITAMIN D DEFICIENCY AND INSUFFICIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Acta Clin Croat 2020;59:109-18. [PMID: 32724281 DOI: 10.20471/acc.2020.59.01.13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Ratajczak AE, Szymczak-Tomczak A, Zawada A, Rychter AM, Dobrowolska A, Krela-Kaźmierczak I. Does Drinking Coffee and Tea Affect Bone Metabolism in Patients with Inflammatory Bowel Diseases? Nutrients 2021;13:216. [PMID: 33451170 DOI: 10.3390/nu13010216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Fiocchi C, Iliopoulos D. What's new in IBD therapy: An "omics network" approach. Pharmacol Res 2020;159:104886. [PMID: 32428668 DOI: 10.1016/j.phrs.2020.104886] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
54 Li M, Wang F, Wang J, Wang A, Yao X, Strappe P, Zhou Z, Wu Q, Guo T. Starch acylation of different short-chain fatty acids and its corresponding influence on gut microbiome and diabetic indexes. Food Chemistry 2022;389:133089. [DOI: 10.1016/j.foodchem.2022.133089] [Reference Citation Analysis]
55 Rojas-Rueda D, Morales-Zamora E, Alsufyani WA, Herbst CH, AlBalawi SM, Alsukait R, Alomran M. Environmental Risk Factors and Health: An Umbrella Review of Meta-Analyses. Int J Environ Res Public Health 2021;18:E704. [PMID: 33467516 DOI: 10.3390/ijerph18020704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
56 Costamagna G. Acute appendicitis: Will a novel endoscopic “organ-sparing” approach change the treatment paradigm? Gastrointestinal Endoscopy 2020;92:190-1. [DOI: 10.1016/j.gie.2020.02.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
57 Wu Z, Huang S, Li T, Li N, Han D, Zhang B, Xu ZZ, Zhang S, Pang J, Wang S, Zhang G, Zhao J, Wang J. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome 2021;9:184. [PMID: 34493333 DOI: 10.1186/s40168-021-01115-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
58 Moon JM, Kang EA, Han K, Hong SW, Soh H, Park S, Lee J, Lee HJ, Im JP, Kim JS. Trends and risk factors of elderly-onset Crohn’s disease: A nationwide cohort study. World J Gastroenterol 2020; 26(4): 404-415 [PMID: 32063689 DOI: 10.3748/wjg.v26.i4.404] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Wang H, Zhang M, Zhang M, Wang F, Liu J, Zhao Q. Carboxypeptidase A6 was identified and validated as a novel potential biomarker for predicting the occurrence of active ulcerative colitis. J Cell Mol Med 2020;24:8803-13. [PMID: 32570281 DOI: 10.1111/jcmm.15517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 de Laffolie J. Epidemiologische Forschung und Behandlungsdatenanalyse zu chronisch-entzündlichen Darmerkrankungen: Verbesserung der Versorgung von Kindern und Jugendlichen. Monatsschr Kinderheilkd 2020;168:298-313. [DOI: 10.1007/s00112-020-00852-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Shen X, Wan Q, Zhao R, Wu Y, Wang Y, Cui Y, Su X, Wu X. Inflammatory bowel diseases and the risk of adverse health outcomes: Umbrella review of meta-analyses of observational studies. Dig Liver Dis 2021;53:809-16. [PMID: 33551353 DOI: 10.1016/j.dld.2021.01.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Mak WY, Zhao M, Ng SC, Burisch J. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol. 2020;35:380-389. [PMID: 31596960 DOI: 10.1111/jgh.14872] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 14.7] [Reference Citation Analysis]
63 Tenailleau QM, Lanier C, Gower-Rousseau C, Cuny D, Deram A, Occelli F. Crohn's disease and environmental contamination: Current challenges and perspectives in exposure evaluation. Environ Pollut 2020;263:114599. [PMID: 32325248 DOI: 10.1016/j.envpol.2020.114599] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
64 Sun S, Xu X, Liang L, Wang X, Bai X, Zhu L, He Q, Liang H, Xin X, Wang L, Lou C, Cao X, Chen X, Li B, Wang B, Zhao J. Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota. Front Immunol 2021;12:777665. [PMID: 34899735 DOI: 10.3389/fimmu.2021.777665] [Reference Citation Analysis]
65 Piovani D, Danese S, Peyrin-Biroulet L, Bonovas S. Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study. J Crohns Colitis 2020;14:323-31. [PMID: 31504350 DOI: 10.1093/ecco-jcc/jjz150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
66 Larussa T, Suraci E, Marasco R, Imeneo M, Abenavoli L, Luzza F. Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization. Medicina (Kaunas) 2019;55:E507. [PMID: 31434334 DOI: 10.3390/medicina55080507] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
67 Tian Y, Zhang D, Nakamura M. Biological Clock and Inflammatory Bowel Disease Review: From the Standpoint of the Intestinal Barrier. Gastroenterology Research and Practice 2022;2022:1-11. [DOI: 10.1155/2022/2939921] [Reference Citation Analysis]
68 Rogler G, Scharl M, Spalinger M, Yilmaz B, Zaugg M, Hersberger M, Schreiner P, Biedermann L, Herfarth H. Diet and Inflammatory Bowel Disease: What Quality Standards Should Be Applied in Clinical and Laboratory Studies? Mol Nutr Food Res 2021;65:e2000514. [PMID: 33433954 DOI: 10.1002/mnfr.202000514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Nakai D, Miyake M, Hashimoto A. Comparison of the Intestinal Drug Permeation and Accumulation Between Normal Human Intestinal Tissues and Human Intestinal Tissues With Ulcerative Colitis. J Pharm Sci 2020;109:1623-6. [PMID: 31870787 DOI: 10.1016/j.xphs.2019.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Snyder EF, Davis S, Aldrich K, Veerabagu M, Larussa T, Abenavoli L, Boccuto L. Crohn disease: Identification, diagnosis, and clinical management. Nurse Pract 2021;46:22-30. [PMID: 34808643 DOI: 10.1097/01.NPR.0000798212.61425.4f] [Reference Citation Analysis]
71 Gao Y, Cai Y, Yang K, Liu M, Shi S, Chen J, Sun Y, Song F, Zhang J, Tian J. Methodological and reporting quality in non-Cochrane systematic review updates could be improved: a comparative study. Journal of Clinical Epidemiology 2020;119:36-46. [DOI: 10.1016/j.jclinepi.2019.11.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
72 Wu Z, Liu X, Huang S, Li T, Zhang X, Pang J, Zhao J, Chen L, Zhang B, Wang J, Han D. Milk Fat Globule Membrane Attenuates Acute Colitis and Secondary Liver Injury by Improving the Mucus Barrier and Regulating the Gut Microbiota. Front Immunol 2022;13:865273. [DOI: 10.3389/fimmu.2022.865273] [Reference Citation Analysis]
73 Pellicano R, Ianiro G, Fagoonee S, Settanni CR, Gasbarrini A. Review: Extragastric diseases and Helicobacter pylori. Helicobacter 2020;25 Suppl 1:e12741. [PMID: 32918343 DOI: 10.1111/hel.12741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
74 Sandall AM, Cox SR, Lindsay JO, Gewirtz AT, Chassaing B, Rossi M, Whelan K. Emulsifiers Impact Colonic Length in Mice and Emulsifier Restriction is Feasible in People with Crohn's Disease. Nutrients 2020;12:E2827. [PMID: 32942699 DOI: 10.3390/nu12092827] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
75 Borchers NS, Santos-Valente E, Toncheva AA, Wehkamp J, Franke A, Gaertner VD, Nordkild P, Genuneit J, Jensen BAH, Kabesch M. Human β-Defensin 2 Mutations Are Associated With Asthma and Atopy in Children and Its Application Prevents Atopic Asthma in a Mouse Model. Front Immunol 2021;12:636061. [PMID: 33717182 DOI: 10.3389/fimmu.2021.636061] [Reference Citation Analysis]
76 Olivera PA, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin DT, Danese S, Peyrin-Biroulet L. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453143 DOI: 10.1038/s41575-021-00492-8] [Reference Citation Analysis]
77 Yoshihara T, Shinzaki S, Amano T, Iijima H, Takehara T, Inoue N, Uchino M, Esaki M, Kobayashi T, Saruta M, Sugimoto K, Nakamura S, Hata K, Hirai F, Hiraoka S, Fujii T, Matsuura M, Matsuoka K, Watanabe K, Nakase H, Watanabe M. Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021;36:1744-53. [PMID: 33450096 DOI: 10.1111/jgh.15401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Kuhnen A. Genetic and Environmental Considerations for Inflammatory Bowel Disease. Surgical Clinics of North America 2019;99:1197-207. [DOI: 10.1016/j.suc.2019.08.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
79 Trakman GL, Fehily S, Basnayake C, Hamilton AL, Russell E, Wilson-O'Brien A, Kamm MA. Diet and gut microbiome in gastrointestinal disease. J Gastroenterol Hepatol 2021. [PMID: 34716949 DOI: 10.1111/jgh.15728] [Reference Citation Analysis]
80 Kim S, Mortera M, Heyn P, Sood P, Wen PS, Chen Wong D, Tanveer S, Hu X. An overview of systematic reviews on the pharmacological randomized controlled trials for reducing intracranial pressure after traumatic brain injury. Brain Inj 2022;:1-12. [PMID: 35708261 DOI: 10.1080/02699052.2022.2087102] [Reference Citation Analysis]
81 Lu M, Zhang T, Lu Z, Wang W, Chen T, Cao Z. A comparison of the efficacy and safety of complementary and alternative therapies for ulcerative colitis: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21219. [PMID: 32664174 DOI: 10.1097/MD.0000000000021219] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Luo X, Wang X, Huang S, Xu B, Luo S, Li Y, Wang Q, Chen Y, Deng X, Liu L, Zhou L. Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway. Int Immunopharmacol 2021;90:107224. [PMID: 33302036 DOI: 10.1016/j.intimp.2020.107224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
83 Chen Z, Zhang X, Xing Z, Lv S, Huang L, Liu J, Ye S, Li X, Chen M, Zuo S, Tao Y, He Y. OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment. Oncogene 2022. [PMID: 35487976 DOI: 10.1038/s41388-022-02324-8] [Reference Citation Analysis]
84 Nishikawa A, Tanaka K, Miyake Y, Nagata C, Furukawa S, Andoh A, Yokoyama T, Yoshimura N, Mori K, Ninomiya T, Yamamoto Y, Takeshita E, Ikeda Y, Saito M, Ohashi K, Imaeda H, Kakimoto K, Higuchi K, Nunoi H, Mizukami Y, Suzuki S, Hiraoka S, Okada H, Kawasaki K, Higashiyama M, Hokari R, Miura H, Miyake T, Kumagi T, Kato H, Hato N, Sayama K, Hiasa Y; Japan Ulcerative Colitis Study Group. Active and passive smoking and risk of ulcerative colitis: A case-control study in Japan. J Gastroenterol Hepatol 2021. [PMID: 34845747 DOI: 10.1111/jgh.15745] [Reference Citation Analysis]
85 Senga SS, Grose RP. Hallmarks of cancer-the new testament. Open Biol 2021;11:200358. [PMID: 33465324 DOI: 10.1098/rsob.200358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
86 Gioxari A, Amerikanou C, Papada E, Zioga E, Georgoulis AD, Bamias G, Kaliora AC. Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases. Nutrients 2020;12:E3734. [PMID: 33291539 DOI: 10.3390/nu12123734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
87 Xavier JB, Young VB, Skufca J, Ginty F, Testerman T, Pearson AT, Macklin P, Mitchell A, Shmulevich I, Xie L, Caporaso JG, Crandall KA, Simone NL, Godoy-Vitorino F, Griffin TJ, Whiteson KL, Gustafson HH, Slade DJ, Schmidt TM, Walther-Antonio MRS, Korem T, Webb-Robertson BM, Styczynski MP, Johnson WE, Jobin C, Ridlon JM, Koh AY, Yu M, Kelly L, Wargo JA. The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View. Trends Cancer 2020;6:192-204. [PMID: 32101723 DOI: 10.1016/j.trecan.2020.01.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
88 Li YY, Wang XJ, Su YL, Wang Q, Huang SW, Pan ZF, Chen YP, Liang JJ, Zhang ML, Xie XQ, Wu ZY, Chen JY, Zhou L, Luo X. Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s. Acta Pharmacol Sin 2022;43:1495-507. [PMID: 34671110 DOI: 10.1038/s41401-021-00781-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Huang G, Wang Z, Wu G, Zhang R, Dong L, Huang F, Zhang M, Su D. Lychee (Litchi chinensis Sonn.) Pulp Phenolics Activate the Short-Chain Fatty Acid-Free Fatty Acid Receptor Anti-inflammatory Pathway by Regulating Microbiota and Mitigate Intestinal Barrier Damage in Dextran Sulfate Sodium-Induced Colitis in Mice. J Agric Food Chem 2021;69:3326-39. [PMID: 33533603 DOI: 10.1021/acs.jafc.0c07407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
90 Teich N, Bruns T, Stallmach A; German IBD Study Group. Appendectomy in childhood-did it save my sibling from getting ulcerative colitis? Int J Colorectal Dis 2021;36:623-4. [PMID: 33098305 DOI: 10.1007/s00384-020-03780-y] [Reference Citation Analysis]
91 Chen M, Liu M, Li C, Peng S, Li Y, Xu X, Sun M, Sun X. Fecal Microbiota Transplantation Effectively Cures a Patient With Severe Bleeding Immune Checkpoint Inhibitor-Associated Colitis and a Short Review. Front Oncol 2022;12:913217. [PMID: 35756645 DOI: 10.3389/fonc.2022.913217] [Reference Citation Analysis]
92 Storman M, Storman D, Jasinska KW, Swierz MJ, Bala MM. The quality of systematic reviews/meta‐analyses published in the field of bariatrics: A cross‐sectional systematic survey using AMSTAR 2 and ROBIS. Obesity Reviews 2020;21. [DOI: 10.1111/obr.12994] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
93 Stallhofer J, Veith L, Diegelmann J, Probst P, Brand S, Schnitzler F, Olszak T, Török H, Mayerle J, Stallmach A, Beigel F. Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. Clin Transl Gastroenterol 2022. [PMID: 35029158 DOI: 10.14309/ctg.0000000000000450] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Axelrad JE, Cadwell KH, Colombel JF, Shah SC. Systematic review: gastrointestinal infection and incident inflammatory bowel disease. Aliment Pharmacol Ther 2020;51:1222-32. [PMID: 32372471 DOI: 10.1111/apt.15770] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
95 Aljabban J, Rohr M, Borkowski VJ, Nemer M, Cohen E, Hashi N, Aljabban H, Boateng E, Syed S, Mohammed M, Mukhtar A, Hadley D, Panahiazar M. Probing predilection to Crohn's disease and Crohn's disease flares: A crowd-sourced bioinformatics approach. Journal of Pathology Informatics 2022. [DOI: 10.1016/j.jpi.2022.100094] [Reference Citation Analysis]
96 Grover S, Dougan M, Tyan K, Giobbie-Hurder A, Blum SM, Ishizuka J, Qazi T, Elias R, Vora KB, Ruan AB, Martin-Doyle W, Manos M, Eastman L, Davis M, Gargano M, Haq R, Buchbinder EI, Sullivan RJ, Ott PA, Hodi FS, Rahma OE. Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis. Cancer. 2020;126:3758-3767. [PMID: 32567084 DOI: 10.1002/cncr.32966] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
97 Li H, Christman LM, Li R, Gu L. Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases. Food Funct 2020;11:4878-91. [PMID: 32490857 DOI: 10.1039/d0fo00713g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
98 Fiocchi C, Iliopoulos D. Inflammatory Bowel Disease Therapy: Beyond the Immunome. Front Immunol 2022;13:864762. [DOI: 10.3389/fimmu.2022.864762] [Reference Citation Analysis]
99 Peppas S, Piovani D, Peyrin-Biroulet L, Danese S, Bonovas S. Statins and inflammatory bowel disease: Where do we stand? Eur J Intern Med 2020;75:10-4. [PMID: 32151491 DOI: 10.1016/j.ejim.2020.02.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
100 Chen W, Qian W, Zhong L, Jing G. Migraine and Medical Ramifications: A Comprehensive Overview Based on Observational Study Meta-Analyses. Front Neurol 2021;12:778062. [PMID: 35002929 DOI: 10.3389/fneur.2021.778062] [Reference Citation Analysis]
101 Zhang L, Yao X, Ma M, Ding Y, Zhang H, He X, Song Z. Protective Effect of l-Theanine against DSS-Induced Colitis by Regulating the Lipid Metabolism and Reducing Inflammation via the NF-κB Signaling Pathway. J Agric Food Chem 2021;69:14192-203. [PMID: 34784210 DOI: 10.1021/acs.jafc.1c05839] [Reference Citation Analysis]
102 Martins KR, Araújo JM, Cruz ÁC, Luiz-Ferreira A. EPIDEMIOLOGIC ASPECTS OF INFLAMMATORY BOWEL DISEASE IN THE WESTERN REGION OF MINAS GERAIS STATE. Arq Gastroenterol 2021;58:377-83. [PMID: 34705974 DOI: 10.1590/S0004-2803.202100000-63] [Reference Citation Analysis]
103 Torres J, Halfvarson J, Rodríguez-lago I, Hedin CRH, Jess T, Dubinsky M, Croitoru K, Colombel J. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Prediction and Prevention of Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021;15:1443-54. [DOI: 10.1093/ecco-jcc/jjab048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
104 Dimnjakovic J, Poljicanin T, Svajda M. Breastfeeding: A standard or an intervention? Review of systematic reviews. Medical Hypotheses 2020;141:109737. [DOI: 10.1016/j.mehy.2020.109737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Fehily SR, Basnayake C, Wright EK, Kamm MA. The gut microbiota and gut disease. Intern Med J 2021;51:1594-604. [PMID: 34664371 DOI: 10.1111/imj.15520] [Reference Citation Analysis]
106 Preiningerova JL, Jiraskova Zakostelska Z, Srinivasan A, Ticha V, Kovarova I, Kleinova P, Tlaskalova-hogenova H, Kubala Havrdova E. Multiple Sclerosis and Microbiome. Biomolecules 2022;12:433. [DOI: 10.3390/biom12030433] [Reference Citation Analysis]
107 Kellermann L, Jensen KB, Bergenheim F, Gubatan J, Chou ND, Moss A, Nielsen OH. Mucosal vitamin D signaling in inflammatory bowel disease. Autoimmun Rev 2020;19:102672. [PMID: 32942038 DOI: 10.1016/j.autrev.2020.102672] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
108 Peng X, Li J, Zhao H, Lai J, Lin J, Tang S. Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials. BMC Endocr Disord 2022;22. [DOI: 10.1186/s12902-022-01015-5] [Reference Citation Analysis]
109 Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:643-54. [PMID: 33121686 DOI: 10.1016/j.gtc.2020.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
110 Piovani D, Pansieri C, Kotha SRR, Piazza AC, Comberg CL, Peyrin-Biroulet L, Danese S, Bonovas S. Ethnic Differences in the Smoking-related Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis 2021;15:1658-78. [PMID: 33721889 DOI: 10.1093/ecco-jcc/jjab047] [Reference Citation Analysis]
111 Kern I, Schoffer O, Kiess W, Henker J, Laaß MW, Winkler U, Quietzsch J, Wenzel O, Zurek M, Büttner K, Fischer P, de Laffolie J, Manuwald U, Stange T, Zenker R, Weidner J, Zimmer KP, Kunath H, Kugler J, Richter T, Rothe U. Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry. PLoS One 2021;16:e0243774. [PMID: 33395450 DOI: 10.1371/journal.pone.0243774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Alemany-Cosme E, Sáez-González E, Moret I, Mateos B, Iborra M, Nos P, Sandoval J, Beltrán B. Oxidative Stress in the Pathogenesis of Crohn's Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics. Antioxidants (Basel) 2021;10:64. [PMID: 33430227 DOI: 10.3390/antiox10010064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
113 Dybska E, Adams AT, Duclaux-Loras R, Walkowiak J, Nowak JK. Waiting in the wings: RUNX3 reveals hidden depths of immune regulation with potential implications for inflammatory bowel disease. Scand J Immunol 2021;93:e13025. [PMID: 33528856 DOI: 10.1111/sji.13025] [Reference Citation Analysis]
114 Mousavi T, Nikfar S, Abdollahi M. Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD). Expert Rev Clin Pharmacol 2021;14:865-88. [PMID: 33993811 DOI: 10.1080/17512433.2021.1925108] [Reference Citation Analysis]
115 Sun YX, Yang GY, Karamacoska D, Wang X, Li YX, Hou WB, Zheng YY, Liu JP, Liu ZL. Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med 2021;2021:1075886. [PMID: 34484384 DOI: 10.1155/2021/1075886] [Reference Citation Analysis]
116 Naeem M, Awan UA, Subhan F, Cao J, Hlaing SP, Lee J, Im E, Jung Y, Yoo J. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Arch Pharm Res 2020;43:153-69. [DOI: 10.1007/s12272-020-01219-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 13.5] [Reference Citation Analysis]
117 Asari T, Kikuchi H, Kawaguchi S, Sakuraba H, Yoshida S, Akemoto Y, Maeda T, Shinji O, Murai Y, Higuchi N, Hoshi K, Fukutoku Y, Hiraga H, Sasaki K, Fukuda S. Polygonum tinctorium leaves suppress sodium dextran sulfate-induced colitis through interleukin-10-related pathway. Biochemistry and Biophysics Reports 2022;30:101272. [DOI: 10.1016/j.bbrep.2022.101272] [Reference Citation Analysis]
118 Chen G, Shen J. Artificial Intelligence Enhances Studies on Inflammatory Bowel Disease. Front Bioeng Biotechnol 2021;9:635764. [PMID: 34307315 DOI: 10.3389/fbioe.2021.635764] [Reference Citation Analysis]
119 Lu Y, Chen J, He X, Xu S, Chen YE, Gao J, Hou S. Combined Administration of Vitamin D3 and Geniposide Is Less Effective than Single Use of Vitamin D3 or Geniposide in the Treatment of Ulcerative Colitis. Front Pharmacol 2021;12:714065. [PMID: 34650431 DOI: 10.3389/fphar.2021.714065] [Reference Citation Analysis]
120 Cheng Z, Si X, Tan H, Zang Z, Tian J, Shu C, Sun X, Li Z, Jiang Q, Meng X, Chen Y, Li B, Wang Y. Cyanidin-3-O-glucoside and its phenolic metabolites ameliorate intestinal diseases via modulating intestinal mucosal immune system: potential mechanisms and therapeutic strategies. Crit Rev Food Sci Nutr 2021;:1-19. [PMID: 34420433 DOI: 10.1080/10408398.2021.1966381] [Reference Citation Analysis]
121 Cho S, Stroup BM, Britto SL, Ruan W, Schady D, Hoffman KL, Kellermayer R. Increased number of children in households may protect against inflammatory bowel disease. Pediatr Res 2022. [PMID: 35701607 DOI: 10.1038/s41390-022-02149-x] [Reference Citation Analysis]
122 Yeh PJ, Chen CC, Chao HC, Lai JY, Hsueh C, Wang CJ, Lai MW. High initial bowel resection rate and very-early-onset inflammatory bowel disease - A challenge in a low-prevalence area. J Formos Med Assoc 2021;120:720-7. [PMID: 32819795 DOI: 10.1016/j.jfma.2020.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Oligschlaeger Y, Yadati T, Houben T, Condello Oliván CM, Shiri-Sverdlov R. Inflammatory Bowel Disease: A Stressed "Gut/Feeling". Cells 2019;8:E659. [PMID: 31262067 DOI: 10.3390/cells8070659] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
124 Zhao H, Xu H, Chen S, He J, Zhou Y, Nie Y. Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease. J Gastroenterol Hepatol 2021;36:320-8. [PMID: 32815163 DOI: 10.1111/jgh.15222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
125 Rath E, Haller D. Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury. Mucosal Immunol. [DOI: 10.1038/s41385-022-00514-x] [Reference Citation Analysis]
126 Le Berre C, Loy L, Lönnfors S, Avedano L, Piovani D. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations. World J Gastroenterol 2020; 26(29): 4343-4355 [PMID: 32848338 DOI: 10.3748/wjg.v26.i29.4343] [Reference Citation Analysis]
127 Park J, Choi TJ, Kang KS, Choi SH. The Interrelationships between Intestinal Permeability and Phlegm Syndrome and Therapeutic Potential of Some Medicinal Herbs. Biomolecules 2021;11:284. [PMID: 33671865 DOI: 10.3390/biom11020284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
128 Lee WS, Song ZL, Wong SY, Gan CW, Koay ZL, Em JM, Chong SY, Lim CB, Wong SY, Chew KS, Kam CC. Environmental risk factors for inflammatory bowel disease: A case control study in Southeast Asian children. J Paediatr Child Health 2021. [PMID: 34761458 DOI: 10.1111/jpc.15830] [Reference Citation Analysis]
129 Lo CH, Khalili H, Song M, Lochhead P, Burke KE, Richter JM, Giovannucci EL, Chan AT, Ananthakrishnan AN. Healthy Lifestyle Is Associated With Reduced Mortality in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2021;19:87-95.e4. [PMID: 32142939 DOI: 10.1016/j.cgh.2020.02.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
130 Ajdacic-Gross V, Steinemann N, Horváth G, Rodgers S, Kaufmann M, Xu Y, Kamm CP, Kesselring J, Manjaly ZM, Zecca C, Calabrese P, Puhan MA, von Wyl V. Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors. Front Neurol 2021;12:693440. [PMID: 34295301 DOI: 10.3389/fneur.2021.693440] [Reference Citation Analysis]
131 Coates MM, Kintu A, Gupta N, Wroe EB, Adler AJ, Kwan GF, Park PH, Rajbhandari R, Byrne AL, Casey DC, Bukhman G. Burden of non-communicable diseases from infectious causes in 2017: a modelling study. Lancet Glob Health 2020;8:e1489-98. [PMID: 33098769 DOI: 10.1016/S2214-109X(20)30358-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
132 Stange EF, Schroeder BO. Microbiota and mucosal defense in IBD: an update. Expert Rev Gastroenterol Hepatol. 2019;13:963-976. [PMID: 31603356 DOI: 10.1080/17474124.2019.1671822] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
133 Zhong L, Wu C, Li Y, Zeng Q, Lai L, Chen S, Tang S. Nonalcoholic fatty liver disease and health outcomes: An umbrella review of systematic reviews and meta-analyses. Therapeutic Advances in Chronic Disease 2022;13:204062232210835. [DOI: 10.1177/20406223221083508] [Reference Citation Analysis]
134 LeBaron TW, Asgharzadeh F, Khazei M, Kura B, Tarnava A, Slezak J. Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice. EXCLI J 2021;20:1106-17. [PMID: 34345230 DOI: 10.17179/excli2021-3762] [Reference Citation Analysis]
135 Agrawal M, Burisch J, Colombel J, C. Shah S. Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations. Journal of Crohn's and Colitis 2020;14:267-73. [DOI: 10.1093/ecco-jcc/jjz139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
136 Piovani D, Danese S, Peyrin-biroulet L, Bonovas S. Inflammatory bowel disease: estimates from the global burden of disease 2017 study. Aliment Pharmacol Ther 2020;51:261-70. [DOI: 10.1111/apt.15542] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
137 Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ, Sasson AN, Agrawal M, Tiong JHT, Steinberg J, Kruis W, Steinwurz F, Ahuja V, Ng SC, Rubin DT, Colombel J, Gearry R, Abreu M, Ahuja V, Allez M, Ananthakrishnan A, Bemelman W, Bernstein C, Braun J, Chowers Y, Colombel J, Danese S, D'haens G, D'hoore A, Dignass A, Dotan I, Dubinsky M, Ekbom A, Fleshner P, Gasche C, Gassull M, Gearry R, Ghosh S, Gibson P, Griffiths A, Halfvarson J, Hanauer S, Harpaz N, Hart A, Hibi T, Kamm M, Kaplan G, Kaser A, Korelitz B, Kotze P, Koutroubakis I, Kruis W, Lakatos P, Lewis J, Lindsay J, Loftus E, Louis E, Lukas M, Magro F, Mahadevan U, Mantzaris G, Mary J, Mcgovern D, Moum B, Munkholm P, Neurath M, Ng S, O'morain C, Oresland T, Panaccione R, Panes J, Panis Y, Pemberton J, Peyrin-biroulet L, Prantera C, Rachmilewitz D, Ran Z, Reinisch W, Remzi F, Rhodes J, Riddell R, Rogler G, Rubin D, Sachar D, Sandborn W, Sands B, Sartor B, Schoelmerich J, Schreiber S, Siegel C, Siegmund B, Silverberg M, Söderholm J, Sood A, Spinelli A, Stange E, Steinwurz F, Targan S, Travis S, Turner D, Tysk C, Vatn M, Vermeire S, Watanabe M, Yamamoto T, Yamamoto-furusho J. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. The Lancet Gastroenterology & Hepatology 2022;7:666-78. [DOI: 10.1016/s2468-1253(22)00021-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Burchiel SW, Lauer FT, Factor-Litvak P, Liu X, Santella RM, Islam T, Eunus M, Alam N, Islam T, Rahman M, Ahmed A, Ahsan H, Graziano J, Parvez F. An increase in circulating B cells and B cell activation markers in peripheral blood is associated with cigarette smoking in a male cohort in Bangladesh. Toxicol Appl Pharmacol 2019;384:114783. [PMID: 31669812 DOI: 10.1016/j.taap.2019.114783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
139 Peng C, Wu C, Xu X, Pan L, Lou Z, Zhao Y, Jiang H, He Z, Ruan B. Indole-3-carbinol ameliorates necroptosis and inflammation of intestinal epithelial cells in mice with ulcerative colitis by activating aryl hydrocarbon receptor. Exp Cell Res 2021;404:112638. [PMID: 34015312 DOI: 10.1016/j.yexcr.2021.112638] [Reference Citation Analysis]
140 Zhu T, Xue Q, Liu Y, Xu Y, Xiong C, Lu J, Yang H, Zhang Q, Huang Y. Analysis of Intestinal Microflora and Metabolites From Mice With DSS-Induced IBD Treated With Schistosoma Soluble Egg Antigen. Front Cell Dev Biol 2021;9:777218. [PMID: 34858992 DOI: 10.3389/fcell.2021.777218] [Reference Citation Analysis]
141 Nair N, Austin C, Curtin P, Gouveia C, Arora M, Torres J, Dubinsky M, Colombel J, Peter I. Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous Teeth. Gastroenterology 2020;159:383-5. [DOI: 10.1053/j.gastro.2020.03.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
142 Zhu L, Zong X, Xiao X, Cheng Y, Fu J, Lu Z, Jin M, Wang F, Wang Y. Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis Mice. Front Immunol 2021;12:773070. [PMID: 35069545 DOI: 10.3389/fimmu.2021.773070] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Rozich JJ, Holmer A, Singh S. Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases. Am J Gastroenterol 2020;115:832-40. [PMID: 32224703 DOI: 10.14309/ajg.0000000000000608] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
144 Yuan Y, Ni S, Zhuge A, Li L, Li B. Adipose-Derived Mesenchymal Stem Cells Reprogram M1 Macrophage Metabolism via PHD2/HIF-1α Pathway in Colitis Mice. Front Immunol 2022;13:859806. [PMID: 35757749 DOI: 10.3389/fimmu.2022.859806] [Reference Citation Analysis]
145 Dhaliwal J, Tuna M, Shah BR, Murthy S, Herrett E, Griffiths AM, Benchimol EI. Incidence of Inflammatory Bowel Disease in South Asian and Chinese People: A Population-Based Cohort Study from Ontario, Canada. Clin Epidemiol 2021;13:1109-18. [PMID: 34876857 DOI: 10.2147/CLEP.S336517] [Reference Citation Analysis]
146 Wong E, Lui K, Day AS, Leach ST. Manipulating the neonatal gut microbiome: current understanding and future perspectives. Arch Dis Child Fetal Neonatal Ed 2021:fetalneonatal-2021-321922. [PMID: 34433586 DOI: 10.1136/archdischild-2021-321922] [Reference Citation Analysis]
147 Zhang J, Walker ME, Sanidad KZ, Zhang H, Liang Y, Zhao E, Chacon-Vargas K, Yeliseyev V, Parsonnet J, Haggerty TD, Wang G, Simpson JB, Jariwala PB, Beaty VV, Yang J, Yang H, Panigrahy A, Minter LM, Kim D, Gibbons JG, Liu L, Li Z, Xiao H, Borlandelli V, Overkleeft HS, Cloer EW, Major MB, Goldfarb D, Cai Z, Redinbo MR, Zhang G. Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract. Nat Commun 2022;13:136. [PMID: 35013263 DOI: 10.1038/s41467-021-27762-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]